Management of cutaneous melanoma.
Tsao
Hensin
H
Department of Dermatology, Massachusetts General Hospital Melanoma Center, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
Atkins
Michael B
MB
Sober
Arthur J
AJ
D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D009367:Neoplasm Staging; D011994:Recombinant Proteins; D012307:Risk Factors; D055502:Secondary Prevention; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D016019:Survival Analysis
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins